OpenURL Connection Search - EBSCO

Connecting you to content on EBSCOhost

Select item for more details and to access through your institution.

Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials.
Published in:
Infectious Diseases & Therapy, 2024, v. 13, n. 6, p. 1253, doi. 10.1007/s40121-024-00970-x
By:
- Levin, Myron J.;
- Ustianowski, Andrew;
- De Wit, Stephane;
- Beavon, Rohini;
- Thissen, Jesse;
- Seegobin, Seth;
- Dey, Kanika;
- Near, Karen A.;
- Streicher, Katie;
- Kiazand, Alexandre;
- Esser, Mark T.
Publication type:
Article
AZD7442 (Tixagevimab/Cilgavimab) for Post-Exposure Prophylaxis of Symptomatic Coronavirus Disease 2019.
Published in:
Clinical Infectious Diseases, 2023, v. 76, n. 7, p. 1247, doi. 10.1093/cid/ciac899
By:
- Levin, Myron J;
- Ustianowski, Andrew;
- Thomas, Steven;
- Templeton, Alison;
- Yuan, Yuan;
- Seegobin, Seth;
- Houlihan, Catherine F;
- Menendez-Perez, Ibrahim;
- Pollett, Simon;
- Arends, Rosalinda H;
- Beavon, Rohini;
- Dey, Kanika;
- Garbes, Pedro;
- Kelly, Elizabeth J;
- Koh, Gavin C K W;
- Ivanov, Stefan;
- Near, Karen A;
- Sharbaugh, Audrey;
- Streicher, Katie;
- Pangalos, Menelas N
Publication type:
Article